Cancel anytime
UnitedHealth Group Incorporated (UNH)UNH
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/19/2024: UNH (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: WEAK BUY |
Historic Profit: -23.01% | Upturn Advisory Performance 3 | Avg. Invested days: 32 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 11/19/2024 |
Type: Stock | Today’s Advisory: WEAK BUY |
Historic Profit: -23.01% | Avg. Invested days: 32 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 11/19/2024 | Upturn Advisory Performance 3 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 552.63B USD |
Price to earnings Ratio 39.07 | 1Y Target Price 623.93 |
Dividends yield (FY) 1.40% | Basic EPS (TTM) 15.37 |
Volume (30-day avg) 3431051 | Beta 0.59 |
52 Weeks Range 433.00 - 630.73 | Updated Date 11/21/2024 |
Company Size Large-Cap Stock | Market Capitalization 552.63B USD | Price to earnings Ratio 39.07 | 1Y Target Price 623.93 |
Dividends yield (FY) 1.40% | Basic EPS (TTM) 15.37 | Volume (30-day avg) 3431051 | Beta 0.59 |
52 Weeks Range 433.00 - 630.73 | Updated Date 11/21/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 3.64% | Operating Margin (TTM) 8.64% |
Management Effectiveness
Return on Assets (TTM) 6.92% | Return on Equity (TTM) 15.25% |
Revenue by Products
Revenue by Products - Current and Previous Year
Valuation
Trailing PE 39.07 | Forward PE 20.12 |
Enterprise Value 593506742567 | Price to Sales(TTM) 1.4 |
Enterprise Value to Revenue 1.53 | Enterprise Value to EBITDA 21.27 |
Shares Outstanding 920284032 | Shares Floating 917753552 |
Percent Insiders 0.23 | Percent Institutions 90.01 |
Trailing PE 39.07 | Forward PE 20.12 | Enterprise Value 593506742567 | Price to Sales(TTM) 1.4 |
Enterprise Value to Revenue 1.53 | Enterprise Value to EBITDA 21.27 | Shares Outstanding 920284032 | Shares Floating 917753552 |
Percent Insiders 0.23 | Percent Institutions 90.01 |
Analyst Ratings
Rating 4.54 | Target Price 558.19 | Buy 5 |
Strong Buy 19 | Hold 4 | Sell - |
Strong Sell - |
Rating 4.54 | Target Price 558.19 | Buy 5 | Strong Buy 19 |
Hold 4 | Sell - | Strong Sell - |
AI Summarization
UnitedHealth Group Incorporated (UNH): A Detailed Overview
Company Profile:
History and Background:
Founded in 1977, UnitedHealth Group Incorporated (UNH) has grown into a leading diversified healthcare company in the U.S. It originated as a single hospital insurer and gradually expanded through mergers and acquisitions into various healthcare sectors like health insurance, pharmacy benefit management, and care delivery.
Core Business Areas:
- UnitedHealthcare: Provides health insurance coverage to over 260 million people worldwide, offering employer-sponsored plans, Medicare and Medicaid products, individual and family coverage, and public sector plans.
- OptumHealth: Offers various healthcare services, including outpatient care, surgical facilities, behavioral health programs, and physician care. This segment also manages pharmacy benefits for clients through OptumRx.
- OptumInsight: This business segment provides data analytics and technology solutions, helping healthcare organizations improve efficiency and quality of care.
Leadership & Structure:
UnitedHealth Group is led by CEO Andrew Witty, with a diverse leadership team overseeing different segments and functionalities. The company operates through a decentralized structure, empowering individual business units with autonomy and accountability.
Top Products and Market Share:
Top Products:
- UnitedHealthcare Individual & Family Plans: Offers health insurance options to individuals and families outside employer-sponsored plans.
- Medicare & Retirement: Provides Medicare Advantage and prescription drug plans to seniors.
- Medicaid Plans: Serves low-income individuals and families with government-sponsored health insurance.
- Commercial Group Plans: Offers comprehensive health insurance solutions to employers and their employees.
- OptumRx: Manages pharmacy benefits for over 90 million members, negotiating prescription drug costs and promoting safe medication practices.
Market Share:
- Leading Market Share: UNH is the largest health insurer in the U.S. by market share, covering nearly 14% of the total market.
- Significant Presence in Medicare & Medicaid: Holds the top spot in Medicare Advantage and the second position in Medicaid programs.
- Strong Pharmacy Benefit Management: OptumRx is the largest pharmacy benefit manager in the U.S., handling prescriptions for almost 28% of the market.
Total Addressable Market (TAM):
The global healthcare market is vast and growing, estimated to reach a value of nearly $12 trillion by 2027. This includes various segments, like health insurance, pharmaceuticals, medical devices, and healthcare services. With its diversified business portfolio, UNH operates in multiple segments within this expansive market.
Financial Performance:
Recent Financial Highlights:
- Revenue: 2022 revenue of $324.2 billion, reflecting year-over-year growth of 12.9%.
- Net Income: Achieved net income of $25.9 billion in 2022, representing a 7.5% increase compared to the previous year.
- Profit Margins: Maintained healthy profit margins, with an operating margin of 7.5% and a net margin of 4.9% in 2022.
- Earnings per Share (EPS): EPS grew to $21.47 in 2022, representing a 7.3% increase from 2021.
Financial Health: UNH demonstrates a strong and growing financial profile. The company consistently generates significant cash flow, maintains a healthy debt-to-equity ratio, and invests in strategic growth areas.
Dividends and Shareholder Returns:
Dividend History: UNH boasts a consistent dividend payment history, increasing dividends annually for 14 consecutive years. The current annual dividend payout is $6.80 per share, representing a yield of about 1.3%.
Shareholder Returns: UNH has provided impressive shareholder returns over different time frames. Its 10-year total return to shareholders stands at approximately 250%.
Growth Trajectory:
Historical Growth: UNH has consistently exhibited solid organic growth in recent years. Over the past five years, revenue has expanded at a compound annual growth rate (CAGR) of 10.5%. Net income also grew steadily, achieving a CAGR of 9.3% in the same period.
Future Projections: Industry analysts project continued growth for UNH, with estimated revenue reaching $383.9 billion in 2024, representing a CAGR of 8.3%. This growth will be driven by factors such as an aging population, increasing healthcare costs, and continued expansion of UNH's core businesses.
Growth Initiatives: UNH actively pursues strategic initiatives to bolster future growth. These include:
- Expanding geographically into new markets
- Developing innovative healthcare technology solutions
- Investing in partnerships and acquisitions to broaden service offerings
Market Dynamics:
The healthcare industry is characterized by constant evolution, driven by advancements in medical technology, shifting regulatory landscapes, and demographic changes. UNH demonstrates strong positioning within this dynamic environment due to its:
- Extensive scale and market share
- Diversified business portfolio
- Focus on innovation and technology
- Adaptability and willingness to address changing market needs
Competitors:
UNH faces competition from other major healthcare companies, including:
- Anthem (ANTM): Market share of 8.3%, focusing on health insurance products.
- CVS Health (CVS): Market share of 7.2%, offering pharmacy services and health insurance plans.
- Cigna (CI): Market share of 6.4%, focusing on health insurance offerings.
- Humana (HUM): Market share of 5.9%, specializing in Medicare Advantage plans.
While these competitors hold considerable market share, UNH maintains a leading position due to its larger scale, broader product offerings, and strong financial performance.
Potential Challenges and Opportunities:
Challenges:
- Stricter regulations and cost pressures in the healthcare industry
- Rapidly evolving technological landscape and increasing competition from technology companies entering the healthcare market
- Managing rising healthcare costs and delivering affordable care
Opportunities:
- Expansion into international markets and emerging economies with growing healthcare needs
- Developing and integrating innovative health technologies to improve patient outcomes and operational efficiency
- Partnerships and acquisitions to further expand service offerings and market reach
Recent Acquisitions (2020-2023):
Change Healthcare (2023): This acquisition aims to enhance UNH's data analytics capabilities and drive efficiency in the healthcare administrative process.
Catamaran (2015): This acquisition of a pharmacy benefit manager strengthened UNH's position in the pharmacy benefit management market.
DaVita Medical Group (2019): This acquisition expanded UNH's network of outpatient medical clinics, enhancing its care delivery capabilities.
These acquisitions reflect UNH's strategic approach to growth through strategic expansion into new segments and enhancing existing business lines.
AI-Based Fundamental Rating:
Overall Rating: 8 out of 10
Justification:
- Strong Financial Health: UNH exhibits consistent revenue growth, robust profitability, and healthy cash flow, indicating a solid financial foundation.
- Leading Market Position: The company holds the top market share in the health insurance industry and occupies strong positions across various healthcare segments.
- Growth Prospects: Future projections anticipate continued growth in revenue and earnings, supported by strategic initiatives.
- Adaptability and Innovation: UNH demonstrates a strong track record of adaptation and investment in technology, positioning itself well to navigate future industry changes.
Disclaimer: This information is for educational purposes only and should not be considered financial advice. Please conduct thorough research and consult with a qualified financial advisor before making investment decisions.
Sources:
- UnitedHealth Group Investor Relations: https://investors.unitedhealthgroup.com/
- MarketWatch: https://www.marketwatch.com/investing/stock/unh
- Statista: https://www.statista.com/topics/5527/health-insurance-in-the-united-states/U.S.
- Forbes: https://www.forbes.com/companies/unitedhealth-group/
- Fierce Healthcare: https://www.fiercehealthcare.com/
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About UnitedHealth Group Incorporated
Exchange | NYSE | Headquaters | Minnetonka, MN, United States |
IPO Launch date | 1984-10-26 | CEO & Non-Independent Director | Sir Andrew Philip Witty |
Sector | Healthcare | Website | https://www.unitedhealthgroup.com |
Industry | Healthcare Plans | Full time employees | 440000 |
Headquaters | Minnetonka, MN, United States | ||
CEO & Non-Independent Director | Sir Andrew Philip Witty | ||
Website | https://www.unitedhealthgroup.com | ||
Website | https://www.unitedhealthgroup.com | ||
Full time employees | 440000 |
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Minnetonka, Minnesota.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.